Smithers Helps Drug Developers With Their Most Challenging Problems

Smithers Helps Drug Developers With Their Most Challenging Problems


Smithers, a bioanalytical contract research organization (CRO), supports the development of large molecule therapeutics from discovery through phase IV, with expertise in bioassays and ultra-sensitivity ligand-binding assays. Our services focus on development, validation and sample analysis for PK/TK, ADA, bioassays and fit-for purpose biomarker studies. Smithers supports biologics/monoclonal polyclonal antibodies/bi-specific antibodies/CAR-T/TCR/ biosimilars and biobetters.

Download Brochure

Smithers-PDS-Overview-Brochure

Latest Resources

See all resources